BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27254104)

  • 21. Relationship between parity and clinical and biological features in patients with systemic sclerosis.
    Launay D; Hebbar M; Hatron PY; Michon-Pasturel U; Queyrel V; Hachulla E; Devulder B
    J Rheumatol; 2001 Mar; 28(3):509-13. PubMed ID: 11296950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic Sclerosis: Exploring the Potential Interplay Between Thyroid Disorders and Pregnancy Outcome in an Italian Cohort.
    Triggianese P; Conigliaro P; Chimenti MS; Barbato C; Greco E; Kroegler B; De Carolis C; Perricone R
    Isr Med Assoc J; 2017 Aug; 19(8):473-477. PubMed ID: 28825764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gynaecologic history in systemic sclerosis.
    Sampaio-Barros PD; Samara AM; Marques Neto JF
    Clin Rheumatol; 2000; 19(3):184-7. PubMed ID: 10870650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favourable outcome of planned pregnancies in systemic sclerosis patients during stable disease.
    Braun J; Balbir-Gurman A; Toledano K; Tavor Y; Braun-Moscovici Y
    Scand J Rheumatol; 2022 Nov; 51(6):513-519. PubMed ID: 34637666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study.
    Hamed HO; Ahmed SR; Alzolibani A; Kamal MM; Mostafa MS; Gamal RM; Atallah DA; Abd-El-Aall DE
    Acta Obstet Gynecol Scand; 2013 Aug; 92(8):934-42. PubMed ID: 23621378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-disease pregnancy complications and systemic sclerosis: pathogenic or pre-clinical?
    Chakravarty E
    Arthritis Res Ther; 2012 Feb; 14(1):102. PubMed ID: 22313964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of topical corticosteroids in pregnancy: a population-based cohort study.
    Chi CC; Mayon-White RT; Wojnarowska FT
    J Invest Dermatol; 2011 Apr; 131(4):884-91. PubMed ID: 21191410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy losses in young Australian women: findings from the Australian Longitudinal Study on Women's Health.
    Herbert D; Lucke J; Dobson A
    Womens Health Issues; 2009; 19(1):21-9. PubMed ID: 19111784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are Women With Uterine Fibroids at Increased Risk for Adverse Pregnancy Outcome?
    Ezzedine D; Norwitz ER
    Clin Obstet Gynecol; 2016 Mar; 59(1):119-27. PubMed ID: 26670833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intrauterine growth retardation in preterm labor and delivery].
    Gogiia TE; Kintraia NP
    Georgian Med News; 2005 Dec; (129):30-3. PubMed ID: 16444024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy and scleroderma.
    Silman AJ
    Am J Reprod Immunol; 1992; 28(3-4):238-40. PubMed ID: 1285889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Systemic sclerosis and pregnancy].
    Launay D; Hebbar M; Valat AS; Ducloy AS; Hachulla E; Hatron PY; Ouk T; Devulder B
    Rev Med Interne; 2002 Jul; 23(7):607-21. PubMed ID: 12162216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retrospective evaluation of pregnancy in women suffering from systemic lupus erythematosus (SLE)].
    Sadowska A; Hebanowski M; Trzeciak B; Kliszcz J; Nowicka-Sauer K; Waldman M
    Ginekol Pol; 2005 Dec; 76(12):955-9. PubMed ID: 16566374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Obstetrical prognosis improvement in patients exposed in utero to diethylstilbestrol with specific care management].
    Amour MC; Mokdad A; Mayenga JM; Belaisch-Allart J
    Gynecol Obstet Fertil; 2004 Nov; 32(11):942-9. PubMed ID: 15567682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease.
    Chakravarty EF; Khanna D; Chung L
    Obstet Gynecol; 2008 Apr; 111(4):927-34. PubMed ID: 18378753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy in scleroderma.
    Steen VD
    Rheum Dis Clin North Am; 2007 May; 33(2):345-58, vii. PubMed ID: 17499711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-Arginine in pregnant scleroderma patients.
    Giuggioli D; Colaci M; Sebastiani M; Ferri C
    Clin Rheumatol; 2010 Aug; 29(8):937-9. PubMed ID: 20213128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States.
    Kawano Y; Kolstad KD; Li S; Simard JF; Chung L
    Semin Arthritis Rheum; 2023 Dec; 63():152252. PubMed ID: 37666113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of subchorionic haemorrhage and pregnancy outcome in threatened miscarriage to predict miscarriage, pre-term labour and intrauterine growth restriction.
    Ozkaya E; Altay M; Gelişen O
    J Obstet Gynaecol; 2011; 31(3):210-2. PubMed ID: 21417641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.